A bill designed to improve treatment opportunities for pediatric cancer patients in the US has passed unanimously through the House of Representatives. The Research to Accelerate Cures and Equity (RACE) for Children Act, which was [...]
Rising drug prices is an issue that can no longer be ignored, and serious efforts are now being made, by multiple different industry stakeholders, to deal with the problem. Bills focused on price cutting initiatives [...]
Two new bills, that would allow drug and device manufacturers to provide more information about their pre-approval and post-approval products, are currently being considered by the House Energy and Commerce Health Subcommittee. The first bill [...]